Zimmer Biomet Holdings, Inc. · NYSE:ZBH

Zimmer Biomet — Zimmer Holdings — Merrill Lynch Conference (February 2004)

33 slides from Zimmer Biomet's conference presentation, Feb 4, 2004

  1. Slide 1: Merrill Lynch Conference

    Merrill Lynch Conference Merrill Lynch Conference Merrill Lynch Conference Ray Elliott Chairman, President and CEO Zimmer Holdings, Inc. Zimmer Holdings, Inc.

  2. Slide 2: Disclaimer

    Disclaimer Zimmer has filed a registration statement, including a proxy statement/prospectus and other relevant materials with the SEC, for the issuance of its shares in connection with the proposed acquisition of Implex. Shareholders of Implex are urged to read the relevant materials when they beco

  3. Slide 3: Today's Presentation

    Today's Presentation 1. Strategic Direction Innovation and Education Investment and Expansion 2. Centerpulse Integration

  4. Slide 4: Zimmer Growth Goals 1998-2003

    New Markets Spine, Sports Med, Pain Mgmt. and IGS New Products "New Patient" Strategies New Geographies Europe Zimmer Growth Goals 1998-2003

  5. Slide 5: But the 2004-2006 Strategies Reflect Fine-Tuning

    But the 2004-2006 Strategies Reflect Fine-Tuning New Geographies New Products New Markets Become Innovation & Education Investment & Expansion Innovation & Education Integration

  6. Slide 6: And the Tactics Too Are More Targeted

    And the Tactics Too Are More Targeted Innovation & Education Investment & Expansion Integration But always dedicated to sales and cashflow excellence. New Patient's Continuum of Care MIS Zimmer Institute Spine Orthobiologics Centerpulse Implex

  7. Slide 7: Zimmer Innovation and Education Review

    Innovation & Education Investment & Expansion Integration New Patient's Continuum of Care MIS Zimmer Institute Spine Orthobiologics Centerpulse Implex Zimmer Innovation and Education Review

  8. Slide 8: Hip Innovation and Education Focus on the New Patient's Continuum of Care

    Hip Innovation and Education Focus on the New Patient's Continuum of Care Innovative, new technologies MIS Implants and Techniques Hip Resurfacing Trabecular Metal, EPOCH Alternate Bearing Computer Assisted Surgery DTC with the surgeon TV, Radio and Magazines pacewithlife.com Public Forums and MLC P

  9. Slide 9: Knee Innovation and Education Focus on the New Patient's Continuum of Care

    Knee Innovation and Education Focus on the New Patient's Continuum of Care Innovative, new technologies MIS Implants and Techniques Focus on Interpositional, CR, Revision, and MB Trabecular Metal New Polyethylene Computer Assisted Surgery Cartilage and Meniscus DTC with the surgeon TV, Radio and Mag

  10. Slide 10: 2-Incision Hip for 2004

    2-Incision Hip for 2004 2-Incision Hip for 2004 First live I-G surgery Patents issuance Procedure tracking EVA beta-site analysis Outcomes publishing Actions

  11. Slide 11: Potentially Five More MIS 2-Incision Patents

    Potentially Five More MIS 2-Incision Patents MIS(tm) 2-Incision Hip MIS(tm) 2-Incision Hip MIS(tm) 2-Incision Hip TITLE NUMBER OF CLAIMS STATUS Lit Anterior Retractor 28 Pending Ligametum Teres Femoris Cutter 42 Pending Method and Apparatus for Performing Total Hip Arthroplasty (broad technique) 17

  12. Slide 12: The Sad Story of Hip Fixation

    The Sad Story of Hip Fixation 4% of patients die during initial hospitalization 25% of patients die within one year of surgery 40% of patients require long- term care 50% of patients never walk unassisted 90% of hip fractures are associated with osteoporosis Source: AAOS, "Hip fracture epidemic requ

  13. Slide 13: Zimmer's Transformational MIS Hip Fixation

    Zimmer's Transformational MIS Hip Fixation First patient surgery trial - March 2004, Australia

  14. Slide 14: Potentially Five More "T2" MIS Hip Fracture Patents

    Potentially Five More "T2" MIS Hip Fracture Patents Hip Fracture Transformation Technologies Hip Fracture Transformation Technologies Hip Fracture Transformation Technologies TITLE NUMBER OF CLAIMS STATUS Contoured Polymer Filled Implant 13 Issued Polymer Filled Hip Fracture Fixation Device 9 Issued

  15. Slide 15: Zimmer MIS "Quad-Sparing" Total Knee

    Zimmer MIS "Quad-Sparing(tm)" Total Knee Zimmer MIS "Quad-Sparing(tm)" Total Knee Mini Medial Parapatellar 9-14 cm 2- 4 cm Quad Snip Standard Knee 20-30 cm Quad incision Mini Sub- Vastus 9-12 cm No Quad Snip Zimmer MIS Quad Sparing(tm) 7-10 cm No Quad Snip Release at AAOS, March 2004

  16. Slide 16: Potentially Seven MIS Knee Patents

    Potentially Seven MIS Knee Patents MIS Knee MIS Knee MIS Knee TITLE NUMBER OF CLAIMS STATUS Minimally Invasive Total Knee Arthroplasty Method & Instrumentation 47 Pending Knee Arthroplasty Prosthesis & Method 62 Pending Patella Resection Guide 36 Pending Femoral Saw Guide & Method 47 Pending Minimal

  17. Slide 17: Zimmer MIS Requires World Class Education

    Zimmer MIS Requires World Class Education 2003 Total Surgeons Trained in Zimmer MIS Institutes MIS 2-Incision MIS "Mini" Hip MIS "Mini" Knee All Other TOTAL 493 1162 1030 687 3372

  18. Slide 18: Zimmer Investment and Expansion Review

    Innovation & Education Investment & Expansion Integration New Patient's Continuum of Care MIS Zimmer Institute Spine Orthobiologics Centerpulse Implex Zimmer Investment and Expansion Review

  19. Slide 19: Zimmer Spine Will Be a Primary Investment

    Integrate Trabecular Metal spine Leverage MIS programs Optimize salesforce leverage Merge disc / nucleus discovery Invest in targeted biologics Expand Non-Fusion Zimmer Spine Will Be a Primary Investment North America Europe Japan Growth Strategies GeoMix

  20. Slide 20: Zimmer Dental Will Provide Diversification

    Zimmer Dental Will Provide Diversification Attractive Market Growth Rate 12-15% Low implant penetration rates Potential positive reimbursement Drive demand with DTC Utilize Zimmer R&D critical mass Transfer "Recon" technologies

  21. Slide 21: Zimmer Orthobiologics Targets the Future

    Cartilage and Soft Tissue Complement to ISTO Program Leverage ReGen/CMI opportunity Launch Permacol(tm) rotator cuff patch Awarded $2MM State of Indiana grant Bone Graft Distribution of Allograft (Tutogen) Distribution License for Structural Acquire Human Growth Factor tech Zimmer Orthobiologics Tar

  22. Slide 22: The "New" Zimmer R&D Investment Focus

    The "New" Zimmer R&D Investment Focus New Zimmer Orthobiologics group Trabecular Metal applications "MIS friendly", conservative implants Transformational hip fracture/spine Creation of "Lifestyle Designs" Image Guidance integration Unique alternate bearings Unique alternate bearings Unique alternat

  23. Slide 23: Centerpulse Integration Review

    Innovation & Education Investment & Expansion Integration New Patient's Continuum of Care MIS Zimmer Institute Spine Orthobiologics Centerpulse Implex Centerpulse Integration Review

  24. Slide 24: Perfect Fit

    Perfect Fit = + Our Deal Remains . . .

  25. Slide 25: Premier, Innovative, Global Orthopaedics Company

    Premier, Innovative, Global Orthopaedics Company Leading Technology MIS Alternate Materials CAS Biologics Disc / Nucleus Leading Scale 100,000+ SKUs 2,000+ sales people 1,000,000+ ft2 mfg 1,000+ patents 100,000+ outcomes Leading Positions #1 Reconstructive #1 Hips #1 Knees #1 Europe #1 US & Japan An

  26. Slide 26: And With the Right Outcome

    And With the Right Outcome . . . JNJ Stryker Zimmer Biomet Centerpulse Smith & Nephew Wright Exactech Other Market Share 23.2 21.4 30 11.4 0.103 7.7 2.6 0.8 3.8 The $6.4 Billion Reconstructive market growing at 13%

  27. Slide 27: Where Are We in the Process?

    Where Are We in the Process? ae [Team process [Trainteam leads ontracking provesstemplates Zen | Mo integration sub-team tracking training) Geb _| Team leads [Tracking templates completed byteams E-feb | Teamleads [Financial activities [One-time sass reconciliation en | __ Wo lHRbaseline andiesues [

  28. Slide 28: Centerpulse Salesforce Integration Update

    Centerpulse Salesforce Integration Update US Sales Force Distributor negotiations & re-alignments complete Inventory & asset verifications in progress Combined sales force effective January 1st, 2004 Single billing system to go live April 1st, 2004 1,000 attendees to first National Sales Meeting Pro

  29. Slide 29: Centerpulse Distributor Status

    Centerpulse Distributor Status Successful completion* Completion is unlikely IMPLANT SOLUTIONS INTERWEST ORTHOPEDICS PROJOINT MEDICAL ORTHO SOURCE H & H GREAT LAKES INNOVATIVE CSA Z-CAROLINA JET STREAM ADVANCED ORTHOPEDICS INLAND ZIMMER ROCKY MTN. CAROLINA SURGICAL WILKINS MEDICAL PRECISION JOINT VE

  30. Slide 30: Targeted Synergies - $'s and Timing

    Targeted Synergies - $'s and Timing 2004 2005 2006 2007 2008 Sales Dis-Synergies $ (50) $ (25) - - - Op Profit from Sales Dis-Synergies (20) (10) - - - Expense synergies: COGS 2 8 30 30 30 R&D 6 15 15 15 15 Selling 2 5 5 5 5 Marketing and Distribution 3 15 15 15 15 G & A 8 23 25 25 25 Total Expense

  31. Slide 31: Implex Trabecular Metal Integration

    Implex Trabecular Metal(tm) Integration "Best Thing Next to Bone" 7 new development projects Recon, Spine and Sports Med Acquiring 100% of Implex stock Anticipated close Qtr. 1, 2004 (r)

  32. Slide 32: The Scoreboard

    Zimmer (+162.46%) S&P HC Equipment & Supplies (+36.18%) S&P 500 (4.40%) Peer Index (+51.51%) (BMET, SNN & SYK) The Scoreboard

  33. Slide 33: Thank You

    Thank You Thank You

Zimmer Holdings — Merrill Lynch Conference (February 2004) on 6ix